Gene Therapy

Boston-headquartered MedTherapy Biotech is expanding its India manufacturing footprint while preparing clinical trials for a lymphoma-focused CAR-T therapy with Cipla

Updated On: 27 May 2026 | 11:33 PM IST

A single gene therapy injection has shown the ability to restore hearing in patients with a specific genetic mutation, with some beginning to respond to sound within weeks

Updated On: 06 Apr 2026 | 3:01 PM IST

CSIR-IGIB and Serum Institute of India have partnered to transfer indigenous CRISPR-based technology that could cut sickle cell gene therapy costs from crores to a fraction

Updated On: 20 Nov 2025 | 12:31 AM IST

The deal will give Lilly access to Adverum's gene therapy candidate, Ixo-vec, and underscores the U.S. drugmaker's focus on such treatments

Updated On: 24 Oct 2025 | 7:54 PM IST

A Phase I/II trial of AMT-130 reports unprecedented results, with patients showing a 75 per cent slowdown in Huntington's disease progression over three years

Updated On: 26 Sep 2025 | 2:40 PM IST

Scientists find that SDR42E1 gene, vital for vitamin D use, could be targeted to treat cancers and immune disorders without harming healthy cells

Updated On: 21 Jul 2025 | 4:40 PM IST

With gene therapy offering new hope for thalassemia, experts urge Indian govt to invest in early diagnosis, genetic testing, and equitable access to treatment

Updated On: 28 May 2025 | 1:18 PM IST

Indian-origin cardiologist Kiran Musunuru leads breakthrough CRISPR gene editing therapy for rare genetic disorder focusing on heart disease genetics and new treatments

Updated On: 16 May 2025 | 12:09 PM IST

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal and external bleeding episodes

Updated On: 11 Dec 2024 | 7:14 PM IST

Dr Reddy's Laboratories is looking to enhance its presence in various emerging segments like nutraceuticals and aims to get into integrated digital healthcare services as part of its future growth plans. In its Annual Report for 2022-23, the Hyderabad-based drug major informed the shareholders that it also intends to follow a disciplined approach towards cash management and acquisitions. "We are exploring business spaces that we think will shape the healthcare of the future. These include deepening our presence in nutraceuticals, cell and gene therapy and new chemical entities (NCEs)," Dr Reddy's Laboratories Chairman K Satish Reddy said. The drug firm is also exploring new spaces such as integrated digital healthcare services, digital therapeutics, and disease management, he added. "While these are long gestation businesses, and we are early in their development, we have made some progress," Reddy said. The drug firm informed the shareholders that it has a strategy in place which

Updated On: 11 Jul 2023 | 2:31 PM IST

Researchers at the University of Maryland School of Medicine (UMSOM) have discovered novel gene mutations responsible for a rare illness that causes heart failure in youngsters

Updated On: 14 May 2023 | 10:15 PM IST

The Indian Institute of Technology Kanpur on Friday said it has licensed a gene therapy technology that has the potential to treat many hereditary eye diseases to Reliance Life Sciences Pvt Ltd. The gene therapy technology from IIT Kanpur will be further developed as an indigenous product by Reliance Life Sciences. Developed by Jayandharan Giridhara Rao and Shubham Maurya from the Department of Biological Sciences and Bioengineering (BSBE), IIT Kanpur, the patented technology modifies the gene of an organism to treat a hereditary disorder, the institute said in a statement. "Gene therapy using viral vectors has recently emerged as a potent tool in the field of molecular medicine. "We believe that this technology holds great promise for treating a wide range of hereditary eye diseases including Leber congenital amaurosis, an eye disorder that is present from birth and Retinitis pigmentosa, a disease causing progressive sustained vision loss," IIT Kanpur Director Abhay Karandikar ...

Updated On: 10 Mar 2023 | 1:58 PM IST

CSL Behring's Hemgenix, administered just once, cut the number of bleeding events expected over the course of a year by 54%, a key study of the therapy found

Updated On: 24 Nov 2022 | 9:46 AM IST

ImmunoACT, backed by Laurus Labs is testing their cancer product

Updated On: 12 Jun 2022 | 9:38 AM IST

Researchers used a genetic engineering strategy to reduce levels of tau--a key protein that accumulates and tangles in brain during the development of Alzheimer's--in an animal model of the condition

Updated On: 20 Mar 2021 | 9:17 AM IST

Putting aside prices for a moment, it's been an exciting period for medical progress

Updated On: 25 Dec 2019 | 8:21 AM IST

The Swiss drugmaker said last week that it was in the process of 'exiting' the Avexis scientists responsible for the manipulation of data on gene therapy Zolgensma

Updated On: 15 Aug 2019 | 12:41 PM IST

The approval of Spark Therapeutics Inc's Luxturna therapy would pave the way for new payment models for drugs, particularly in the US

Updated On: 14 Oct 2017 | 11:23 PM IST

The key to making the therapy work? One of medicine's greatest villains: HIV

Updated On: 07 Oct 2017 | 10:22 PM IST